EUVIMEDEUVIMED entdecken
Open Access

DPP4 Substrate Supplementation Protects From WNT‐Induced Lipid Depletion in Dermal Adipocytes

Suneeti R Madhavan iD, Piper Moore iD, Qiannan Ma iD, Radhika P Atit iD

Experimental Dermatology · 2026

DOI: 10.1111/exd.70354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2026. Verfasst von Suneeti R Madhavan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Dipeptidyl Peptidase 4, Adipocytes, Lipid Metabolism, Gastric Inhibitory Polypeptide. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Scleroderma Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipocytes exhibit remarkable plasticity, dynamically gaining and losing lipid content. However, during skin fibrosis, this adaptability becomes detrimental as adipocytes undergo lipid depletion associated with disease pathology. We previously identified the WNT signalling pathway—acting through Dipeptidyl Peptidase IV (DPP4) – as a key mediator of lipid depletion associated with skin fibrosis, but the mechanism remains unclear. DPP4 is an exopeptidase that cleaves a wide array of substrates across different cell types. Here, we investigate whether modulation of lipid‐regulating DPP4 substrates is sufficient to preserve lipid content in WNT‐activated dermal adipocytes. Using two complementary strategies, we found that supplementation with the DPP4 substrates Neuropeptide Y (NPY) and Glucose‐dependent Insulinotropic Peptide (GIP) can partially protect lipid content in dermal adipocytes. When used in combination, we found that the protection against lipid depletion was more effective than monotherapy alone. These findings demonstrate that supplementation with DPP4 substrates provides a basis for targeted treatments for lipodystrophy syndromes and skin fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl Peptidase 4AdipocytesLipid MetabolismGastric Inhibitory PolypeptideAnimalsWnt Signaling PathwayHumansMiceFibrosisSkin

Stichwörter der Autor:innen

adipocyteslipidlipid depletion

Substanzen

Dipeptidyl Peptidase 4Gastric Inhibitory Polypeptide

Autor:innen und Institutionen

  • Department of Biology, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.

ORCID-Profile: Suneeti R Madhavan, Piper Moore, Qiannan Ma, Radhika P Atit

Förderung

  • NIAMS NIH HHS
  • National Scleroderma Foundation
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Madhavan, S. R., Moore, P., Ma, Q., & Atit, R. P. (2026). DPP4 Substrate Supplementation Protects From WNT‐Induced Lipid Depletion in Dermal Adipocytes. Experimental Dermatology. https://doi.org/10.1111/exd.70354

Vancouver

Madhavan SR, Moore P, Ma Q, Atit RP. DPP4 Substrate Supplementation Protects From WNT‐Induced Lipid Depletion in Dermal Adipocytes. Experimental Dermatology. 2026. doi:10.1111/exd.70354

BibTeX
@article{Madhavan2026,
  author = {Madhavan, Suneeti R and Moore, Piper and Ma, Qiannan and Atit, Radhika P},
  title = {DPP4 Substrate Supplementation Protects From WNT‐Induced Lipid Depletion in Dermal Adipocytes},
  journal = {Experimental Dermatology},
  year = {2026},
  doi = {10.1111/exd.70354}
}
Kostenlos starten →